省部共同推进泰州医药高新区建设联席会议召开

Core Viewpoint - The meeting focused on the development of the Taizhou Medical High-tech Zone, emphasizing the importance of the biopharmaceutical industry in China's health strategy and its role in driving new productive forces [1] Industry Development - The biopharmaceutical industry is a key area for the construction of a healthy China and has been identified as a strategic emerging industry in Jiangsu, leading the nation in both scale and innovation capabilities [1] - Over the past decade, Taizhou has achieved significant growth in the biopharmaceutical sector, transitioning from non-existence to a prominent industry, and has become a vital showcase for "Healthy Jiangsu" [1] Collaborative Mechanism - The establishment of a joint provincial and ministerial mechanism has led to notable achievements in policy implementation, project establishment, pilot programs, and personnel exchanges within the China Medical City [1] - The meeting proposed further improvements to the joint meeting mechanism, focusing on collaborative innovation, open innovation in the industrial chain, emphasizing the role of enterprises in innovation, and creating a supportive innovation ecosystem [1] - There is a call to accelerate the integration of innovation chains, industrial chains, financial chains, and talent chains to enhance the core competitiveness of China Medical City [1]